Have you expressed your interest in the 2024 Lung Cancer Preceptorship? Registrations closing October 1. Date: 22 - 23 November 2024 Location: Brisbane Find out more > buff.ly/3MkapUG

We've had so much interest since the ASM in being a part of a TOGA Working Group and WE HEARD YOU! The Working Group page is now live for you to be part of the research concept development process: buff.ly/3ySIBnA

All trainees and early fellows.....if you sign up to Thoracic Oncology Group of Australasia lung cancer preceptorship, you will get an opportunity to be mentored by this serious-looking oncologist bit.ly/4d65UZa

Congratulations Lauren B Going from strength to strength

ANZ trainees and early fellows- Hear Prunella Blinman give this presentation at the Thoracic Oncology Group of Australasia preceptorship Register bit.ly/4d65UZa

ANZ trainees and early fellows- Hear Prunella Blinman give this presentation at the Thoracic Oncology Group of Australasia lung cancer preceptorship Register bit.ly/4d65UZa ausyoungoncs

Congratulations to Australia's own Prof Kwun Fong on the Adi F. Gazdar IASLC Merit Award.

Yes!!!! We like the immuno-logical explanations!

and a huge Twitter fan base in Aus as well drglaucomflecken

Great discussion at #WCLC24 by Dr Chee Lee of really exciting early phase data from studies of 2 new TKIs with activity in HER2 mutant NSCLC. High response rates and acceptable toxicity.

It would be great to have this in patient-friendly language. In Aus we have reimbursed NGS panels (RNA & DNA), but we don't use the term biomarker testing. Lots of confusion, misinformation & fear of missing out results. #LCSM

#TOGAASM25 ?????

Our 2023 Preceptors had glowing feedback from last year's Preceptorship! Secure your spot at the 2024 Lung Cancer Preceptorship. Registrations closing 1 October. Date: 22 - 23 November 2024 Location: Brisbane Find out more > buff.ly/3MkapUG

Looks like immunosurveillance, or rather lack thereof, does still play a role in the model of air pollution and lung cancer 👏@Drclareweeden

For those following along at home...Aus RadOncResearch makes an appearance on Lung cancer considered Monday WCLC highlights Features the HER2 studies & POLESTAR, which is similar to LAURA trial adding Osi after chemorads in unresectable Stage III NSCLC #WCLC24 iaslc.org/iaslc-news/lun…